Related Experiment Video

Updated: May 7, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

[Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)]

Rafael Cantón1, Patricia Ruiz-Garbajosa

  • 1Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España; Unidad de Resistencia a Antibióticos y Virulencia Bacteriana asociada al Consejo Superior de Investigaciones Científicas, Madrid, España.

Enfermedades Infecciosas Y Microbiologia Clinica
|September 18, 2013
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant enterococci pose significant healthcare challenges. New resistant strains and transmission routes necessitate integrated control strategies combining antibiotic stewardship and patient screening.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Context:

  • Healthcare-associated infections (HAIs) remain a significant challenge, particularly those caused by antibiotic-resistant bacteria.
  • Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant enterococci (MDRE) exhibit evolving resistance patterns, including resistance to vancomycin, linezolid, and decreased susceptibility to daptomycin.
  • Emergence of new MRSA clones (e.g., ST398) linked to livestock and novel mec variants (mecC) that evade current molecular detection methods complicates containment efforts.

Purpose:

  • To highlight the escalating challenges posed by multidrug-resistant pathogens in healthcare settings.
  • To underscore the need for updated and comprehensive strategies to control the spread of MRSA and MDRE.
  • To emphasize the importance of integrating antibiotic stewardship with epidemiological surveillance and patient management.

Summary:

  • Multidrug-resistant pathogens, including MRSA and MDRE, continue to be problematic in nosocomial infections.
  • Emerging resistance mechanisms, new clones (ST398), and novel mec variants (mecC) present significant containment challenges.
  • Reduced susceptibility to last-resort antibiotics like daptomycin and vancomycin, alongside emerging ampicillin resistance in Enterococcus faecium due to beta-lactamase production, are critical concerns.

Impact:

  • Effective control requires a multifaceted approach, integrating antibiotic stewardship programs with robust epidemiological measures.
  • Early detection of colonized patients is crucial for reducing colonization pressure and preventing transmission within healthcare facilities.
  • Addressing these evolving threats is vital for preserving the efficacy of existing antimicrobial agents and protecting patient safety.
Keywords:
Control de infección nosocomialEnterococcus spp.Methicillin resistanceNosocomial infection controlResistencia a la meticilinaResistencia a la vancomicinaStaphylococcus aureusVancomycin resistance

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...